Three double-dose reinforced hepatitis B revaccination scheme for patients with cirrhosis unresponsive to the standard regimen: an open-label randomised clinical trial
Article in Gut (March 2023)
The most recent citing publications are shown below. View all 32 publications that cite this research output on Dimensions.
Efficacy of a two-dose hepatitis B vaccination with a novel immunostimulatory sequence adjuvant (Heplisav-B) on patients with chronic liver disease: a retrospective study
Article in Translational Gastroenterology and Hepatology (January 2023)
Impaired anti-HBV vaccine response in non-cirrhotic chronic HCV is not overcome by double dose regimen: randomized control trial
Article in Annals of Hepatology (December 2022)